CS-NEURO-1
Pre-clinical- Indications
- Neurobehavioral disorders
Company intelligence / Profile preview
Cannabis Science, Inc.
Irvine, California, United Statescannabisscience.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Preclinical
01
Overview
Cannabis Science focused on developing cannabinoid-based pharmaceuticals for serious illnesses including skin cancers and HIV/AIDS. The company had several preclinical/early-stage programs but did not achieve FDA approval for any therapy before its SEC license was revoked in October 2019. It engaged in multiple academic collaborations but has not reported recent clinical results or commercial launches.
- Therapeutic areas
- OncologyHematologyPsychiatryNeurologyInfectious Diseases
- Modalities
- Cannabinoid-based therapies (phytocannabinoids)Plant-based medicinesDNA-based immunotherapeutics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
IGXBio – collaboration to develop GenePro DNA immunotherapeutic drug for HIV/AIDSDana-Farber Cancer Institute – research into cannabinoids for various cancers/blood disordersStellenbosch University – chronic pelvic pain/prostatitis/pain management research
Beyond the preview
Go deeper on Cannabis Science, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cannabis Science, Inc..